VBL Therapeutics Selected for €17.5 Million of Funding from Horizon Europe EIC Accelerator Program
VBL Therapeutics Selected for €17.5 Million of Funding from Horizon Europe EIC Accelerator Program - read this article along with other careers information, tips and advice on BioSpace
Dror Harats Exchange Commission European Innovation Council Business Acceleration Services Vascular Biogenics Ltd European Commission
Source: biospace.com